Leon Chen serves as Executive at LogicBio Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Leon Chen has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 16, 2022 involved selling 22,333 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 16, 2022 | LOGC | $0 | Disposition | 22,333 | $N/A | Discretionary |
Leon Chen currently holds 0 shares of LogicBio Therapeutics, Inc. (LOGC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Leon Chen has been a net neutral trader of LOGC stock. They have purchased $0 and sold $0 worth of shares.
Leon Chen's most recent insider trade was on Nov 16, 2022, when they sold 22,333 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted